A biomarker describes a measurable indicator of a patient's clinical condition that can be
measured accurately and reproducibly. Biomarkers offer utility for diagnosis, prognosis …

Sepsis is now defined as a life-threatening syndrome of organ dysfunction triggered by a
dysregulated host response to infection, posing significant challenges in critical care. The …

Background Early recognition is a key factor to achieve improved outcomes for septic
patients. Combinations of biomarkers, as opposed to single ones, may improve timely …

Background Early and accurate diagnosis of sepsis is challenging. Although procalcitonin
and presepsin have been identified as potential biomarkers to differentiate between sepsis …

Appropriate recognition of bacterial infections in health care setting is the basis for effective
treatment and control of infectious diseases. The positivity rate of traditional methods is low …

Sepsis is a condition characterized by high morbidity and mortality which is commonly
encountered in an emergency and critical care setting. Despite a substantial body of …

Background Biomarker could be objective and reliable tools to predict mortality in sepsis.
We explored the prognostic utilities of emerging biomarkers in septic patients and …

The diagnosis and treatment of sepsis have always been a challenge for the physician,
especially in critical care setting such as emergency department (ED), and currently sepsis …

Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host
response to infection. In 2017, almost 50 million cases of sepsis were recorded worldwide …

Biomarkers to guide antibiotic treatment decisions have been proposed as an effective way
to enhancing a more appropriate use of antibiotics. As a biomarker, procalcitonin (PCT) has …